vs
Astrana Health, Inc.（ASTH）与帕兰提尔科技（PLTR）财务数据对比。点击上方公司名可切换其他公司
帕兰提尔科技的季度营收约是Astrana Health, Inc.的1.5倍（$1.4B vs $950.5M），帕兰提尔科技净利率更高（43.3% vs 0.7%，领先42.6%），帕兰提尔科技同比增速更快（70.0% vs 42.9%），帕兰提尔科技自由现金流更多（$764.0M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 48.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
帕兰提尔科技是美国上市企业，专注研发数据集成与分析平台，为政府机构、军方及各行业企业提供多源数据整合分析能力。旗下核心产品Gotham与Foundry可打通相互孤立的数据库，广泛支撑情报作业、反恐分析、执法工作及企业级数据分析场景。
ASTH vs PLTR — 直观对比
营收规模更大
PLTR
是对方的1.5倍
$950.5M
营收增速更快
PLTR
高出27.1%
42.9%
净利率更高
PLTR
高出42.6%
0.7%
自由现金流更多
PLTR
多$770.0M
$-6.0M
两年增速更快
ASTH
近两年复合增速
48.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.4B |
| 净利润 | $6.6M | $608.7M |
| 毛利率 | — | 84.6% |
| 营业利润率 | 1.9% | 40.9% |
| 净利率 | 0.7% | 43.3% |
| 营收同比 | 42.9% | 70.0% |
| 净利润同比 | 184.4% | 670.4% |
| 每股收益（稀释后） | $0.12 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHPLTR
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.2B | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $883.9M | ||
| Q4 24 | $665.2M | $827.5M | ||
| Q3 24 | $478.7M | $725.5M | ||
| Q2 24 | $486.3M | $678.1M | ||
| Q1 24 | $404.4M | $634.3M |
净利润ASTHPLTR
| Q4 25 | $6.6M | $608.7M | ||
| Q3 25 | $373.0K | $475.6M | ||
| Q2 25 | $9.4M | $326.7M | ||
| Q1 25 | $6.7M | $214.0M | ||
| Q4 24 | $-7.8M | $79.0M | ||
| Q3 24 | $16.1M | $143.5M | ||
| Q2 24 | $19.2M | $134.1M | ||
| Q1 24 | $14.8M | $105.5M |
毛利率ASTHPLTR
| Q4 25 | — | 84.6% | ||
| Q3 25 | — | 82.4% | ||
| Q2 25 | — | 80.8% | ||
| Q1 25 | — | 80.4% | ||
| Q4 24 | — | 78.9% | ||
| Q3 24 | — | 79.8% | ||
| Q2 24 | — | 81.0% | ||
| Q1 24 | — | 81.7% |
营业利润率ASTHPLTR
| Q4 25 | 1.9% | 40.9% | ||
| Q3 25 | 2.0% | 33.3% | ||
| Q2 25 | 3.1% | 26.8% | ||
| Q1 25 | 3.3% | 19.9% | ||
| Q4 24 | 0.1% | 1.3% | ||
| Q3 24 | 5.9% | 15.6% | ||
| Q2 24 | 6.2% | 15.5% | ||
| Q1 24 | 7.5% | 12.8% |
净利率ASTHPLTR
| Q4 25 | 0.7% | 43.3% | ||
| Q3 25 | 0.0% | 40.3% | ||
| Q2 25 | 1.4% | 32.6% | ||
| Q1 25 | 1.1% | 24.2% | ||
| Q4 24 | -1.2% | 9.5% | ||
| Q3 24 | 3.4% | 19.8% | ||
| Q2 24 | 3.9% | 19.8% | ||
| Q1 24 | 3.7% | 16.6% |
每股收益（稀释后）ASTHPLTR
| Q4 25 | $0.12 | $0.24 | ||
| Q3 25 | $0.01 | $0.18 | ||
| Q2 25 | $0.19 | $0.13 | ||
| Q1 25 | $0.14 | $0.08 | ||
| Q4 24 | $-0.14 | $0.03 | ||
| Q3 24 | $0.33 | $0.06 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.31 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $7.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $7.4B |
| 总资产 | $2.2B | $8.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHPLTR
| Q4 25 | $429.5M | $7.2B | ||
| Q3 25 | $463.4M | $6.4B | ||
| Q2 25 | $342.1M | $6.0B | ||
| Q1 25 | $260.9M | $5.4B | ||
| Q4 24 | $290.8M | $5.2B | ||
| Q3 24 | $350.3M | $4.6B | ||
| Q2 24 | $327.7M | $4.0B | ||
| Q1 24 | $337.3M | $3.9B |
股东权益ASTHPLTR
| Q4 25 | $779.3M | $7.4B | ||
| Q3 25 | $775.5M | $6.6B | ||
| Q2 25 | $765.5M | $5.9B | ||
| Q1 25 | $745.4M | $5.4B | ||
| Q4 24 | $712.7M | $5.0B | ||
| Q3 24 | $704.6M | $4.5B | ||
| Q2 24 | $678.9M | $4.1B | ||
| Q1 24 | $653.5M | $3.8B |
总资产ASTHPLTR
| Q4 25 | $2.2B | $8.9B | ||
| Q3 25 | $2.2B | $8.1B | ||
| Q2 25 | $1.4B | $7.4B | ||
| Q1 25 | $1.3B | $6.7B | ||
| Q4 24 | $1.4B | $6.3B | ||
| Q3 24 | $1.3B | $5.8B | ||
| Q2 24 | $1.3B | $5.2B | ||
| Q1 24 | $1.2B | $4.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $777.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $764.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 54.3% |
| 资本支出强度资本支出/营收 | 0.3% | 0.9% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.28× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $2.1B |
8季度趋势，按日历期对齐
经营现金流ASTHPLTR
| Q4 25 | $-2.9M | $777.3M | ||
| Q3 25 | $10.0M | $507.7M | ||
| Q2 25 | $90.9M | $539.3M | ||
| Q1 25 | $16.6M | $310.3M | ||
| Q4 24 | $-10.9M | $460.3M | ||
| Q3 24 | $34.0M | $419.8M | ||
| Q2 24 | $23.2M | $144.2M | ||
| Q1 24 | $6.0M | $129.6M |
自由现金流ASTHPLTR
| Q4 25 | $-6.0M | $764.0M | ||
| Q3 25 | $7.4M | $500.9M | ||
| Q2 25 | $89.5M | $531.6M | ||
| Q1 25 | $13.6M | $304.1M | ||
| Q4 24 | $-13.5M | $457.2M | ||
| Q3 24 | $31.7M | $415.8M | ||
| Q2 24 | $20.4M | $141.3M | ||
| Q1 24 | $5.6M | $126.9M |
自由现金流率ASTHPLTR
| Q4 25 | -0.6% | 54.3% | ||
| Q3 25 | 0.8% | 42.4% | ||
| Q2 25 | 13.7% | 53.0% | ||
| Q1 25 | 2.2% | 34.4% | ||
| Q4 24 | -2.0% | 55.3% | ||
| Q3 24 | 6.6% | 57.3% | ||
| Q2 24 | 4.2% | 20.8% | ||
| Q1 24 | 1.4% | 20.0% |
资本支出强度ASTHPLTR
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 0.6% | ||
| Q2 25 | 0.2% | 0.8% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 0.4% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.4% |
现金转化率ASTHPLTR
| Q4 25 | -0.44× | 1.28× | ||
| Q3 25 | 26.69× | 1.07× | ||
| Q2 25 | 9.65× | 1.65× | ||
| Q1 25 | 2.48× | 1.45× | ||
| Q4 24 | — | 5.83× | ||
| Q3 24 | 2.11× | 2.92× | ||
| Q2 24 | 1.21× | 1.08× | ||
| Q1 24 | 0.40× | 1.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PLTR
| Geographic Concentration Risk | $1.1B | 77% |
| Other | $330.4M | 23% |
